Clinical Trial Update: Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial examining secondary debulking surgery with or without hyperthermic intraperitoneal chemotherapy for stage III ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED